首页> 美国卫生研究院文献>Asian Pacific Journal of Cancer Prevention : APJCP >Potential of Aucklandia Lappa Decne Ethanolic Extract to Trigger Apoptosis of Human T47D and Hela Cells
【2h】

Potential of Aucklandia Lappa Decne Ethanolic Extract to Trigger Apoptosis of Human T47D and Hela Cells

机译:奥克兰拉帕Decne乙醇提取物触发人T47D和Hela细胞凋亡的潜力。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Breast and cervical cancers are global health concerns and major cause of deaths among women. Current treatments such as chemotherapy are associated with several drawbacks that limit their effectiveness. Several anticancer remedies have been found with natural products in the past and the search continues for more examples. Cytotoxic natural compounds may have considerable benefits for cancer therapy either in potentiating the impact of chemotherapy or curtailment of harmful effects. Therefore, discovery and identification of new drugs for breast and cervical cancer treatment are of high priority. The present study addressed the potential role of the ALD (Aucklandia lappa Decne) in suppressing proliferation of T-47D, HeLa and HEp-2 cells in comparison with the non-cancer HCC1937 BL cell line. Treatment with an ALD extract of T-47D, HeLa, and HEp-2 cells resulted in reduction in cell viability in MMT assays. Furthermore, lyophilized ALD principally suppressed cancer cell line growth and proliferation through induction of either intrinsic or extrinsic apoptotic pathways as demonstrated by significantly suppressed release of LDH, and NO production in a dose-dependent manner, and activation of death receptors in T-47D and HeLa cells but not the HEp-2 cell line. Interestingly, lyophilized ALD significantly (p<0.005) repressed the growth of HEp-2 and T-47D cells after treatment for 48hrs while 24hrs treatment significantly suppressed T-47D and HeLa cells. We report for the first time that lyophilized ALD selectively influences apoptosis through alternative apoptotic pathways in both breast and cervical human cancer cells.
机译:乳腺癌和宫颈癌是全球健康问题,也是妇女死亡的主要原因。诸如化学疗法之类的当前疗法与限制其有效性的若干缺点有关。过去,天然产物已经发现了几种抗癌药物,并且继续寻找更多实例。细胞毒性天然化合物在增强化疗效果或减少有害作用方面可能对癌症治疗具有可观的益处。因此,用于乳腺癌和宫颈癌治疗的新药物的发现和鉴定是高度优先的。与非癌HCC1937 BL细胞系相比,本研究解决了ALD(Aucklandia lappa Decne)在抑制T-47D,HeLa和HEp-2细胞增殖中的潜在作用。用T-47D,HeLa和HEp-2细胞的ALD提取物处理导致MMT分析中细胞活力的降低。此外,冻干的ALD主要通过诱导内在或外在凋亡途径来抑制癌细胞系的生长和增殖,这通过显着抑制LDH的释放和NO的剂量依赖性以及T-47D和T-47D中死亡受体的活化来证明。 HeLa细胞,但不是HEp-2细胞系。有趣的是,冻干的ALD在处理48小时后显着(p <0.005)抑制了HEp-2和T-47D细胞的生长,而24小时处理则显着抑制了T-47D和HeLa细胞。我们首次报道冻干的ALD通过乳腺癌和宫颈人类癌细胞中的替代凋亡途径选择性影响凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号